scholarly journals Assessment of Fluorodeoxyglucose F18–Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules

JAMA Surgery ◽  
2018 ◽  
Vol 153 (4) ◽  
pp. 329 ◽  
Author(s):  
Amelia W. Maiga ◽  
Stephen A. Deppen ◽  
Sarah Fletcher Mercaldo ◽  
Jeffrey D. Blume ◽  
Chandler Montgomery ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
High Risk ◽  
Fluorodeoxyglucose F18 ◽  
Emission Tomography ◽  
Lung Nodules ◽  
Positron Emission

Early Prediction of Therapy Outcome in Patients with High-Risk Soft Tissue Sarcoma Using Positron Emission Tomography

Onkologie ◽  
2008 ◽  
Vol 31 (3) ◽  
pp. 107-112 ◽  
Author(s):  
Bernd Kasper ◽  
Sascha Dietrich ◽  
Antonia Dimitrakopoulou-Strauss ◽  
Ludwig G. Strauss ◽  
Uwe Haberkorn ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
High Risk ◽  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Emission Tomography ◽  
Therapy Outcome ◽  
Early Prediction ◽  
Positron Emission

Fluorodeoxyglucose F18 positron emission tomography in a case of slowly progressive pure alexia

Neurocase ◽  
2013 ◽  
Vol 20 (4) ◽  
pp. 476-479
Author(s):  
Jonathan Graff-Radford ◽  
Eduardo E. Benarroch ◽  
Joseph R. Duffy ◽  
Daniel A. Drubach
Keyword(s):  
Positron Emission Tomography ◽  
Fluorodeoxyglucose F18 ◽  
Emission Tomography ◽  
Pure Alexia ◽  
Positron Emission

scholarly journals Can 68Ga-prostate specific membrane antigen positron emission tomography/computerized tomography provide an accurate lymph node staging for patients with medium/high risk prostate cancer? A diagnostic meta-analysis

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Lei Peng ◽  
Jinze Li ◽  
Chunyang Meng ◽  
Jinming Li ◽  
Chengyu You ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Positron Emission Tomography ◽  
Lymph Node ◽  
High Risk ◽  
Meta Analysis ◽  
Diagnostic Value ◽  
Emission Tomography ◽  
Positron Emission ◽  
Psma Pet ◽  
Pet Ct

Abstract Objective This article aims to evaluate the diagnostic value of 68Gallium-PSMA positron emission tomography/computerized tomography (68Ga-PSMA PET/CT) for lymph node (LN) staging in patients with prostate cancer (PCa) by a meta-analysis of diagnostic tests. Methods We systematically retrieved articles from Web of Science, EMBASE, Cochrane Database, PubMed. The time limit is from the creation of the database until June 2019, and Stata 15 was used for calculation and statistical analyses. Results Sensitivity, specificity, positive and negative likelihood ratio (PLR, NLR), diagnostic odds ratio (DOR) and 95% confidence intervals (CI) be used to evaluate the diagnostic value. A total of 10 studies were included in our meta-analysis, which included 701 individuals. The results of each consolidated summary are as follows: sensitivity of 0.84 (95% CI 0.55–0.95), specificity of 0.95 (95% CI 0.87–0.98), PLR and NLR was 17.19 (95% CI 6.27, 47.17) and 0.17 (95% CI 0.05–0.56), respectively. DOR of 100 (95% CI 18–545), AUC of 0.97 (95% CI 0.95–0.98). Conclusion Our study demonstrates that 68Ga-PSMA PET/CT has a high overall diagnostic value for LN staging in patients with moderate and high-risk PCa. But our conclusions still require a larger sample size, multi-center prospective randomized controlled trial to verify.

Sign in / Sign up

Export Citation Format

Share Document